Nymox Pharmaceutical Corporation NYMXF
0.04 USD 0.00 (+0.00%)
Regular-session close
0.035 Day range 0.035
0.0002 52-week range 0.1999
- YTD
- -12.94%
- 1 year
- -65.00%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 6.65M | 12.50M | 11.72M | 13.38M | 10.80M | |
| 3.77M | 6.66M | 8.12M | 7.38M | 6.68M | |
| 2.88M | 5.85M | 3.60M | 6.01M | 4.13M | |
| -6.65M | -12.50M | -11.72M | -13.32M | -10.64M | |
| 43.00K | 39.00K | 42.00K | 38.00K | 18.00K | |
| -6.58M | -12.54M | -11.74M | -13.16M | -10.59M | |
| -6.58M | -12.54M | -11.74M | -13.16M | -10.59M | |
| -6.58M | -12.54M | -11.74M | -13.16M | -10.59M | |
| -6.58M | -12.54M | -11.74M | -13.16M | -10.59M | |
| -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | |
| -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | |
| -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | |
| -6.53M | -12.50M | -11.70M | -13.12M | -10.58M | |
| -6.53M | -12.50M | -11.70M | -13.12M | -10.58M | |
| 89.38M | 81.98M | 73.82M | 68.84M | 60.47M | |
| 89.38M | 81.98M | 73.82M | 68.84M | 60.47M |